Legal & General Group’s ArriVent BioPharma AVBP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $322K | Buy |
14,790
+1,197
| +9% | +$26.1K | ﹤0.01% | 2551 |
|
|
2025
Q1 | $251K | Sell |
13,593
-34
| -0.2% | -$629 | ﹤0.01% | 2578 |
|
|
2024
Q4 | $363K | Buy |
13,627
+10,783
| +379% | +$287K | ﹤0.01% | 2566 |
|
|
2024
Q3 | $66.8K | Buy |
2,844
+1,890
| +198% | +$44.4K | ﹤0.01% | 2763 |
|
|
2024
Q2 | $17.7K | Buy |
954
+58
| +6% | +$1.08K | ﹤0.01% | 3073 |
|
|
2024
Q1 | $16.1K | Buy |
+896
| New | +$16.1K | ﹤0.01% | 3054 |
|